22 reports of this reaction
3.1% of all ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE reports
#2 most reported adverse reaction
VOMITING is the #2 most commonly reported adverse reaction for ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE, manufactured by OPMX LLC. There are 22 FDA adverse event reports linking ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE to VOMITING. This represents approximately 3.1% of all 712 adverse event reports for this drug.
Patients taking ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE who experience vomiting should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
VOMITING is moderately reported among ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE users, representing a notable but not dominant share of adverse events.
In addition to vomiting, the following adverse reactions have been reported for ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE:
The following drugs have also been linked to vomiting in FDA adverse event reports:
VOMITING has been reported as an adverse event in 22 FDA reports for ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
VOMITING accounts for approximately 3.1% of all adverse event reports for ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE, making it one of the most commonly reported side effect.
If you experience vomiting while taking ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.